Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial.

DOI:10.1016/S2213-8587(23)00388-1
作者：Yiming Mu,?Xiaolei Bao,?Freddy G Eliaschewitz,?Morten Rix Hansen,?Bom Taeck Kim,?Anna Koroleva,?Ronald C W Ma,?Tao Yang,?Ning Zu,?Ming Liu
文献类型：期刊论文
补充材料：只需要正文